Behfar, A., Yamada, S., Crespo-Diaz, R., Nesbitt, J.J., Rowe, L.A., Perez-terzic, C., Gaussin, V., Homsy, C., Bartunek, J. and Terzic, A. (2010) Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. Journal of the American College of Cardiology, 56, 721-734. doi:10.1016/j.jacc.2010.03.066

has been cited by the following article:

• TITLE: Hematopoietic stem cells are a critical sub-population of whole bone marrow in the treatment of myocardial infarction

  AUTHORS: Philip Davy, Brienne Walker, Livingston Wong, Richard Allsopp

  KEYWORDS: Hematopoietic Stem Cells; Myocardial Infarction; Transplantation; Cardiac Disease

  JOURNAL NAME: Stem Cell Discovery, Vol.3 No.2, April 23, 2013

  ABSTRACT: Recent studies suggest that whole bone marrow (WBM) derived stem cells may facilitate recovery following myocardial infarction. However, the sub-population of WBM responsible for recovery remains uncertain. By adjusting the abundance of CD34+LinNeg cells in human bone marrow we examined the relative significance of hematopoietic stem cells (HSC) in the recovery of cardiac function in a murine model of induced myocardial infarction. Enrichment of HSC by ~100-fold in WBM transplanted into mice significantly increased recovery of heart function and reduced scar size compared to transplantation of WBM depleted in HSC by ~10-fold (P P P P